ACI	autologous chondrocyte implantation
aHS API	autologous human serum active pharmaceutical ingredient
ASA	American Society of Anesthesiologists
ATIMP	advanced therapy investigational medicinal product
ATMP	advanced therapy medicinal product
cATMP	combined advanced therapy medicinal product
cGMP	current good manufacturing practices
CH	Helvetic Confederation
CHUV	centre hospitalier universitaire vaudois
CPC	cell production center
CPP	critical process parameter
CPR	Plastic and Reconstructive Surgery Service
CQA	critical quality attribute
DMSO	dimethyl sulfoxide
DNA	deoxyribonucleic acid
EC	European Commission
EDTA	ethylenediaminetetraacetic acid
EMA	European Medicines Agency
EU	European Union
FBS	fetal bovine serum
FDA	US Food and Drug Administration
GMP	good manufacturing practices
HAC	human articular chondrocytes
HCV	hepatitis C virus
HIV	human immunodeficiency virus
ICRS	International Cartilage Regeneration and Joint Preservation Society
IMPD	investigational medicinal product dossier
IPC	in-process control
KPP	key process parameter
KQA	key quality attribute
MCB	master cell bank
OTR	Orthopedics and Traumatology Service
Ph. Eur.	European pharmacopoeia
PPC	post-process control
PRP	platelet-rich plasma
QA	quality assurance
QC	quality control
RAM	risk analysis matrix
RH	relative humidity
RT-PCR	real-time polymerase chain reaction
TrSt	standardized transplant product
USA	United States of America
UTR	Regenerative Therapy Unit
WCB	working cell bank